FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3043287524> ?p ?o ?g. }

• W3043287524 endingPage "692.e3" @default.
• W3043287524 startingPage "686" @default.
• W3043287524 abstract "Background Little is known about the longitudinal course of adult atopic dermatitis (AD) lesional severity and extent in clinical practice. Objective To determine the longitudinal course of AD in clinical practice. Methods A prospective, dermatology practice–based study was performed (n = 400). Patients were assessed at baseline and approximately 6, 12, 18, and 24 months by eczema area and severity index (EASI) and objective–scoring atopic dermatitis (objective-SCORAD). Multivariable repeated measures linear regression models were constructed to evaluate AD severity over time. Results Overall, 36.2% and 18.2% of patients had moderate (6.0-22.9) or severe (23.0-72.0) EASI scores at any visit, respectively. Similarly, 29.0% and 26.4% of patients had moderate (24.0-37.9) or severe (38.0-83.0) objective-SCORAD scores at any visit, respectively. Among patients with baseline moderate (6.0-22.9) or severe (23.0-72.0) EASI scores, 25.0% and 18.6% continued to have moderate or severe scores at 1 or more follow-up visits, respectively. Similarly, among patients with baseline moderate (24.0-37.9) or severe (38.0-83.0) objective-SCORAD scores, 22.6% and 24.5% continued to have moderate or severe scores at 1 or more follow-up visits, respectively. In longitudinal regression models, EASI was significantly associated with body surface area (adjusted β [95% confidence interval]: 0.16 [0.09-0.23]) and edema/papulation (2.31 [0.19-4.43]). In addition, objective-SCORAD was significantly associated with body surface area (0.12 [0.04-0.21]), edema/papulation (4.69 [2.05-7.32]), and scratch (3.34 [0.45-6.24]) over time. Conclusion AD lesional severity has a heterogeneous longitudinal course. Many patients had fluctuating lesional severity scores over time. A minority of patients had persistently moderate or severe lesions over time. Most patients with moderate-severe disease at baseline were unable to achieve persistent lesional clearance." @default.
• W3043287524 created "2020-07-23" @default.
• W3043287524 creator A5004642372 @default.
• W3043287524 creator A5011739266 @default.
• W3043287524 creator A5027986596 @default.
• W3043287524 creator A5046198231 @default.
• W3043287524 creator A5055616921 @default.
• W3043287524 creator A5071401036 @default.
• W3043287524 creator A5072302657 @default.
• W3043287524 date "2020-12-01" @default.
• W3043287524 modified "2023-10-09" @default.
• W3043287524 title "A real-world study of the longitudinal course of adult atopic dermatitis severity in clinical practice" @default.
• W3043287524 cites W1262550248 @default.
• W3043287524 cites W1585812603 @default.
• W3043287524 cites W1612101546 @default.
• W3043287524 cites W1902788227 @default.
• W3043287524 cites W1976497498 @default.
• W3043287524 cites W2001485228 @default.
• W3043287524 cites W2014434238 @default.
• W3043287524 cites W2025817860 @default.
• W3043287524 cites W2037957822 @default.
• W3043287524 cites W2047781584 @default.
• W3043287524 cites W2060621834 @default.
• W3043287524 cites W2075843060 @default.
• W3043287524 cites W2092150495 @default.
• W3043287524 cites W2109506046 @default.
• W3043287524 cites W2116661861 @default.
• W3043287524 cites W2117147045 @default.
• W3043287524 cites W2117359358 @default.
• W3043287524 cites W2120110016 @default.
• W3043287524 cites W2142289238 @default.
• W3043287524 cites W2143138262 @default.
• W3043287524 cites W2147102429 @default.
• W3043287524 cites W2300630231 @default.
• W3043287524 cites W2345037755 @default.
• W3043287524 cites W2513454888 @default.
• W3043287524 cites W2593244680 @default.
• W3043287524 cites W2611252451 @default.
• W3043287524 cites W2613543041 @default.
• W3043287524 cites W2778077703 @default.
• W3043287524 cites W2794131071 @default.
• W3043287524 cites W2883568898 @default.
• W3043287524 cites W2884232193 @default.
• W3043287524 cites W2888917798 @default.
• W3043287524 cites W2897204831 @default.
• W3043287524 cites W2900785060 @default.
• W3043287524 cites W2904694536 @default.
• W3043287524 cites W2908530488 @default.
• W3043287524 cites W2921312740 @default.
• W3043287524 cites W2946322933 @default.
• W3043287524 cites W2949491609 @default.
• W3043287524 doi "https://doi.org/10.1016/j.anai.2020.07.005" @default.
• W3043287524 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32682980" @default.
• W3043287524 hasPublicationYear "2020" @default.
• W3043287524 type Work @default.
• W3043287524 sameAs 3043287524 @default.
• W3043287524 citedByCount "12" @default.
• W3043287524 countsByYear W30432875242021 @default.
• W3043287524 countsByYear W30432875242022 @default.
• W3043287524 countsByYear W30432875242023 @default.
• W3043287524 crossrefType "journal-article" @default.
• W3043287524 hasAuthorship W3043287524A5004642372 @default.
• W3043287524 hasAuthorship W3043287524A5011739266 @default.
• W3043287524 hasAuthorship W3043287524A5027986596 @default.
• W3043287524 hasAuthorship W3043287524A5046198231 @default.
• W3043287524 hasAuthorship W3043287524A5055616921 @default.
• W3043287524 hasAuthorship W3043287524A5071401036 @default.
• W3043287524 hasAuthorship W3043287524A5072302657 @default.
• W3043287524 hasConcept C126322002 @default.
• W3043287524 hasConcept C142724271 @default.
• W3043287524 hasConcept C16005928 @default.
• W3043287524 hasConcept C1862650 @default.
• W3043287524 hasConcept C188816634 @default.
• W3043287524 hasConcept C2776173921 @default.
• W3043287524 hasConcept C2777501473 @default.
• W3043287524 hasConcept C2777895361 @default.
• W3043287524 hasConcept C2778329239 @default.
• W3043287524 hasConcept C2779134260 @default.
• W3043287524 hasConcept C2779974597 @default.
• W3043287524 hasConcept C2780501606 @default.
• W3043287524 hasConcept C2780699399 @default.
• W3043287524 hasConcept C30036603 @default.
• W3043287524 hasConcept C44249647 @default.
• W3043287524 hasConcept C71924100 @default.
• W3043287524 hasConceptScore W3043287524C126322002 @default.
• W3043287524 hasConceptScore W3043287524C142724271 @default.
• W3043287524 hasConceptScore W3043287524C16005928 @default.
• W3043287524 hasConceptScore W3043287524C1862650 @default.
• W3043287524 hasConceptScore W3043287524C188816634 @default.
• W3043287524 hasConceptScore W3043287524C2776173921 @default.
• W3043287524 hasConceptScore W3043287524C2777501473 @default.
• W3043287524 hasConceptScore W3043287524C2777895361 @default.
• W3043287524 hasConceptScore W3043287524C2778329239 @default.
• W3043287524 hasConceptScore W3043287524C2779134260 @default.
• W3043287524 hasConceptScore W3043287524C2779974597 @default.
• W3043287524 hasConceptScore W3043287524C2780501606 @default.
• W3043287524 hasConceptScore W3043287524C2780699399 @default.
• W3043287524 hasConceptScore W3043287524C30036603 @default.

• next